ACTR-62. PHASE I TRIAL OF TG02 PLUS DOSE-DENSE OR METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE ASTROCYTOMA IN ADULTS

Jing Wu, Christine Bryla, Yu-Ting Su, Ewa Grajkowska, Ann McCoy, Lisa Boris, Ramya Antony, Nancy Garren, Christine Siegel, Christine Cordova, Orwa Aboud, Elizabeth Vera, Tracy Lawhon, Marta Penas-Prado, Brett Theeler, Tito Mendoza, Terri Armstrong, Ying Yuan, Mark Gilbert

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalNeuro-oncology
Volume21
DOIs
StatePublished - Nov 11 2019
Externally publishedYes

Disciplines

  • Oncology
  • Internal Medicine
  • Medicine and Health Sciences

Cite this